The study conducted by the Larsson et al 2016 showed that high PODXL expression predicted worse overall survival (OS) in CRC when compared with the low PODXL expression in cohort II, however, no significant correlation between the PODXL expression and OS was observed in cohort III [11]. This evidence concerns the gene PODXL and colorectal carcinoma.